TWD 37.6
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -682.46 Million TWD | -152.55% |
2022 | -270.23 Million TWD | -166.2% |
2021 | -93.01 Million TWD | -9.01% |
2020 | -83.46 Million TWD | 24.67% |
2019 | -116.97 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -92.46 Million TWD | -202.22% |
2024 Q1 | -36.37 Million TWD | 88.6% |
2023 Q2 | -64.72 Million TWD | 30.45% |
2023 Q4 | -268.49 Million TWD | 0.0% |
2023 Q1 | -93.05 Million TWD | -79.44% |
2023 FY | - TWD | -152.55% |
2023 Q3 | -268.49 Million TWD | -314.85% |
2022 Q3 | -51.85 Million TWD | 0.0% |
2022 FY | - TWD | -166.2% |
2022 Q4 | -51.85 Million TWD | 0.0% |
2021 FY | - TWD | -9.01% |
2020 FY | - TWD | 24.67% |
2019 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -1375.783% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 273.387% |
Level Biotechnology Inc. | 98.7 Million TWD | 791.422% |
Sagittarius Life Science Corp | -44.73 Million TWD | -1425.427% |
NeoCore Technology Co., Ltd. | -72.11 Million TWD | -846.351% |
TaiMed Biologics Inc. | -25.23 Million TWD | -2604.637% |
GlycoNex Incorporation | -126.82 Million TWD | -438.104% |
VBI | -6.97 Million TWD | -9688.597% |
GeneReach Biotechnology Corp. | -143.69 Million TWD | -374.937% |
Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 3229.12% |
SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -3750.056% |
Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -558.651% |
Visgeneer Inc. | 973 Thousand TWD | 70239.877% |
Mycenax Biotech Inc. | -339.48 Million TWD | -101.03% |
Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 172.876% |
G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 783.575% |
Neith Corporation | -33.61 Million TWD | -1930.53% |
Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 31.141% |
TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -39189.637% |
Enimmune corporation | -228.96 Million TWD | -198.066% |
TaiRx, Inc. | -208.64 Million TWD | -227.09% |
CHO Pharma, Inc. | -277.73 Million TWD | -145.727% |
EirGenix Inc. | -664.4 Million TWD | -2.717% |
BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 1023.443% |
Sunny Pharmtech Inc. | 69.14 Million TWD | 1087.028% |
Lin BioScience, Inc. | -1.07 Billion TWD | 36.302% |
BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -503.382% |
Feng Chi Biotech Corp. | 34.83 Million TWD | 2058.956% |
Bio Preventive Medicine Corp. | -62.34 Million TWD | -994.723% |
Lukas Biomedical Inc. | -26.3 Million TWD | -2494.909% |
RBC Bioscience Corporation | 36.54 Million TWD | 1967.352% |
BiOptic Inc. | 65.03 Million TWD | 1149.327% |
Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -1967.688% |
Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -1142.759% |
Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 257.41% |
Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -752.309% |
NaviFUS Corp. | -55.79 Million TWD | -1123.158% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -4011.706% |
Sinew Pharma Inc. | -163.63 Million TWD | -317.073% |
Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -1009.693% |
Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 454.706% |
Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | -201.071% |
AP Biosciences Inc | -325.51 Million TWD | -109.657% |
Medigen Biotechnology Corp. | -1.04 Billion TWD | 34.669% |
3D Global Biotech Inc. | -35.84 Million TWD | -1803.869% |
Pharmosa Biopharm Inc. | 29.13 Million TWD | 2442.812% |
Intech Biopharm Corporation | -219.58 Million TWD | -210.796% |
Oneness Biotech Co., Ltd. | -674.22 Million TWD | -1.221% |
Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -1418.233% |
TWi Biotechnology, Inc. | -160.85 Million TWD | -324.266% |
Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 204.11% |
TCI GENE Inc. | 25.98 Million TWD | 2726.77% |
MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -516.841% |
Senhwa Biosciences, Inc. | -283.78 Million TWD | -140.485% |
Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -367.535% |
NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 5027.516% |
PharmaEngine, Inc. | 347.3 Million TWD | 296.501% |
Savior Lifetec Corporation | 219.6 Million TWD | 410.768% |
TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 496.25% |
OBI Pharma, Inc. | -855.08 Million TWD | 20.188% |
Meribank Biotech Co., Ltd | -92.56 Million TWD | -637.294% |
Acepodia, Inc. | -764.51 Million TWD | 10.733% |
Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | -48.332% |